Karyopharm Therapeutics | Lucro Operacional



Operating Profit Alterar Data
AbbVie USD 3.73B 5.22B 2025-03
Abbott USD 1.66B 253M 2025-03
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Incyte USD 205.17M 96.34M 2025-03
J&J USD 13.63B 9.74B 2025-03
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Takeda JPY -74932000000 141.87B 2025-03
Tectonic Therapeutic USD -13991000 5.65M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Xencor USD -43183000 47.23M 2025-03



Karyopharm Therapeutics Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.